Search

Your search keyword '"Hsieh, Hsing-Pang"' showing total 456 results

Search Constraints

Start Over You searched for: Author "Hsieh, Hsing-Pang" Remove constraint Author: "Hsieh, Hsing-Pang"
456 results on '"Hsieh, Hsing-Pang"'

Search Results

3. Design of drug-like hepsin inhibitors against prostate cancer and kidney stones

9. Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment.

13. Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer

19. Identification of Entry Inhibitors against Delta and Omicron Variants of SARS-CoV-2

20. Additional file 1 of A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies

21. Additional file 1 of Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer

22. Additional file 1 of Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma

23. Additional file 3 of Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma

25. Discovery of BPR1R024, an Orally Active and Selective CSF1R Inhibitor that Exhibits Antitumor and Immunomodulatory Activity in a Murine Colon Tumor Model

43. Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitors

44. A selective Aurora-A 5′-UTR siRNA inhibits tumor growth and metastasis

Catalog

Books, media, physical & digital resources